Medizinische Universität Graz Austria/Österreich - Forschungsportal - Medical University of Graz
Gewählte Publikation:
SHR Neuro Krebs Kardio Lipid Stoffw Microb
Deng, S; Kruger, A; Schmidt, A; Metzger, A; Yan, T; Gödtel-Armbrust, U; Hasenfuss, G; Brunner, F; Wojnowski, L.
Differential roles of nitric oxide synthase isozymes in cardiotoxicity and mortality following chronic doxorubicin treatment in mice.
Naunyn Schmiedebergs Arch Pharmacol. 2009; 380(1): 25-34.
Doi: 10.1007/s00210-009-0407-y
[OPEN ACCESS]
Web of Science
PubMed
FullText
FullText_MUG
- Co-Autor*innen der Med Uni Graz
- Schmidt Albrecht
- Altmetrics:
- Dimensions Citations:
- Plum Analytics:
- Scite (citation analytics):
- Abstract:
- The roles of individual nitric oxide synthases (NOS) in anthracycline-related cardiotoxicity are not completely understood. We investigated the effects of a chronic treatment with doxorubicin (DOX) on knockouts of the individual NOS isozymes and on transgenic mice with myocardial overexpression of eNOS. Fractional shortening (FS) was reduced in untreated homozygous nNOS and iNOS knockouts as well as in eNOS transgenics. DOX-induced FS decrease in wild-type mice was attenuated only in eNOS knockouts, which were found to overexpress nNOS. No worsening of contractility was observed in DOX-treated eNOS transgenics and iNOS knockouts. Although the surviving DOX-treated nNOS knockouts exhibited no further impairment in contractility, most (70%) animals died within 7 weeks after treatment onset. In comparison to untreated wild-type hearts, the nitric oxide (NO) level was lower in hearts from DOX-treated wild-type mice and in all three untreated knockouts. DOX treatment had no effect on NO in the knockouts. These data indicate differential roles of the individual NOS in DOX-induced cardiotoxicity. Protection against DOX effects conferred by eNOS deletion may be mediated by a compensatory overexpression of nNOS. NOS inhibition-based prevention of anthracycline-induced cardiotoxicity should be eNOS-selective, simultaneously avoiding inhibiting nNOS.
- Find related publications in this database (using NLM MeSH Indexing)
- Animals -
- Antibiotics, Antineoplastic - administration and dosage Antibiotics, Antineoplastic - toxicity
- Disease Models, Animal -
- Doxorubicin - administration and dosage Doxorubicin - toxicity
- Heart Diseases - chemically induced Heart Diseases - mortality Heart Diseases - physiopathology
- Mice -
- Mice, Inbred C57BL -
- Mice, Knockout -
- Mice, Transgenic -
- Myocardial Contraction - drug effects
- Nitric Oxide - metabolism
- Nitric Oxide Synthase Type I - genetics Nitric Oxide Synthase Type I - metabolism
- Nitric Oxide Synthase Type II - genetics Nitric Oxide Synthase Type II - metabolism
- Nitric Oxide Synthase Type III - genetics Nitric Oxide Synthase Type III - metabolism
- Survival Rate -
- Find related publications in this database (Keywords)
- Cardiotoxicity
- Mortality
- Nitric oxide synthase
- Doxorubicin